Penumbra 

€278.65
0
-€2.65-0.94% Thursday 06:03

Statistics

Day High
278.65
Day Low
278.65
52W High
305
52W Low
197.35
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

4AugExpected
Q4 2025
Next
Next
0.88
0.92
0.96
1
Expected EPS
0.9994494052799999
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 0P8.MU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Boston Scientific
BSX
Mkt Cap83.97B
Boston Scientific offers a wide range of medical devices that compete with Penumbra's neurovascular and peripheral vascular products.
Medtronic
MDT
Mkt Cap102.71B
Medtronic provides medical devices for various conditions, including those that overlap with Penumbra's market, such as neurovascular devices.
Smith & Nephew
SNN
Mkt Cap13.3B
Smith & Nephew competes in the medical technology market, offering products that can be used in similar procedures as Penumbra's.
Stryker
SYK
Mkt Cap112.88B
Stryker operates in the medical technology field, offering neurotechnology and spine products that compete with Penumbra's offerings.
Zimmer Biomet
ZBH
Mkt Cap16.05B
Zimmer Biomet competes in the musculoskeletal healthcare market, which can overlap with Penumbra's interventional therapies.
Edwards Lifesciences
EW
Mkt Cap48.42B
Edwards Lifesciences specializes in heart valves and hemodynamic monitoring, competing in the broader cardiovascular market with Penumbra.
Intuitive Surgical
ISRG
Mkt Cap162.13B
Intuitive Surgical, known for its robotic surgical systems, competes in the high-tech end of medical devices, indirectly competing with Penumbra's innovative solutions.
Johnson & Johnson
JNJ
Mkt Cap546.9B
Johnson & Johnson, through its medical devices segment, offers a broad range of products that compete across several of Penumbra's markets.
Integra Lifesciences
IART
Mkt Cap830.03M
Integra LifeSciences offers products in neurosurgery, reconstructive and general surgery, directly competing with some of Penumbra's surgical solutions.

About

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25; MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, aspiration pump, and other components and accessories under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that include the Penumbra Coil 400, for the treatment of aneurysms and other complex lesions, detachable coils of neurovascular lesions under the Penumbra SMART COIL, SwiftSET, and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, it provides peripheral embolization products, such as Ruby Embolization Platform, which consists of detachable coils for peripheral applications; Ruby LP and XL Embolization Platform; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; Packing Coil LP; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising the Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. It sells its products through direct sales organizations and distributors. The company was incorporated in 2004 and is based in Alameda, California.
Show more...
CEO
Mr. Adam Elsesser J.D.
Employees
4700
Country
United States
ISIN
US70975L1070

Listings

0 Comments

Share your thoughts

FAQ

What is Penumbra stock price today?
The current price of 0P8.MU is €278.65 EUR — it has decreased by -0.94% in the past 24 hours. Watch Penumbra stock price performance more closely on the chart.
What is Penumbra stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Penumbra stocks are traded under the ticker 0P8.MU.
Is Penumbra stock price growing?
0P8.MU stock has fallen by -0.94% compared to the previous week, the month change is a -1.29% fall, over the last year Penumbra has showed a +7.46% increase.
When is the next Penumbra earnings date?
Penumbra is going to release the next earnings report on August 04, 2026.
How many employees does Penumbra have?
As of May 06, 2026, the company has 4,700 employees.
In which sector is Penumbra located?
Penumbra operates in the Health & Wellness sector.
When did Penumbra complete a stock split?
Penumbra has not had any recent stock splits.
Where is Penumbra headquartered?
Penumbra is headquartered in Alameda, United States.